Yiannoukas Medical Laboratories Ltd (YML) was established in 1975 by Dr. Nicos S. Yiannouka and its headquarters are located in Strovolos area Nicosia Cyprus. During 2000 his son Mr. Kyriakos N. Yiannouka joined the company, bringing the idea to expand the laboratory through the establishment of smaller sub-branches aiming to bring YML's services closer to its users.
As a result of this idea, over the years, YML offers its services through seven (7) other smaller sub-branches in Nicosia, (1) in Larnaca (In cooperation with Mr. Costas Yiannoukas Laboratory) and with the use of mobile blood sampling units with highly qualified phlebotomists in Limassol area. These sub-branches act as sampling centers where the public can have its blood and other specimens taken for examination. Samples are transferred fast and efficiently, using YML's own private logistic services, to its main Laboratory in Nicosia.
Aiming at easiness of access, credibility and quality of results, YML was among the very first labs to be accredited with the ISO – 15189. Nowadays being able to foresee the need for an increased range of services and immediate adaption of new techniques and innovation in examinations, YML recently became the latest member of Biomedicine Healthcare Group of companies, which is the leading private provider of primary health care services in Greece.
At Yiannoukas Medical Laboratories we believe that our constant Quest for Excellence and Provision of Innovative and Easily Accessible health services will always be the means to achieve our primary goal for continuous upgrading of our services and improvement of the wellbeing of all citizens.
Biomedicine Healthcare Group of Companies is a 100% Greek owned and operating group of companies, active in the medical services sector since 1981. It is the leading private provider of primary health care services in Greece, with more than 2,600 employees, 700 of which are specialized doctors, 32 autonomous diagnostic centers covering a total area of 44.700m2, and more than 2,500,000 individuals receiving the group’s services annually. The group also consists of 3 private clinics, in Athens, Piraeus & Thessaloniki, models of modern high-quality hospitals, a center for cross border patients and 4 dental units (Athens, Alimos, Kifissia, Thessaloniki). The Group cooperates with more than 450 private companies, the largest insurance companies and all public insurance funds.
It is noteworthy that Biomedicine Healthcare GoC in a constantly changing social and economic environment continues its steady expansion process by implementing both a domestic in Greece and a multidimensional abroad investment program aiming to expand group's activities to other European countries. Part of this program was the recent acquisition of the majority stake in Yiannoukas Medical Laboratories Ltd, which became a member of the Group's family.
Commitment of the Group's President and Managing Director Evangelos Spanos is to continuously upgrade the services provided to improve the quality of life of people by providing innovative and easily accessible health services to all citizens.
Nicos Yiannouka received his BSc in Clinical Biochemistry from the University of Salford in 1967 and a year later his MSc in Medical Virology and Bacteriology from the University of Manchester. In 1970 he was awarded a PhD by the University of Manchester for his research on "Inducible Enzymes".
Between 1967 - 1970 he was chief clinical laboratory assistant at Manchester University Hospital and between 1970 - 1972 he was assistant to the principal biochemist Salford Royal Infirmary.
In 1973 he returned to Cyprus and established himself in private practice as a sole practitioner until 1975 when he established YML. Nicos Yiannouka is a member of the American Association of Clinical Chemistry, the Association of Clinical Biochemists UK, and a Fellow of the Chemical Society UK, also an associate of the Royal Institute of Chemistry.
He has published several articles on Osteoporosis, Lipids and Atherosclerosis, Allergy, and Disorders of Lipid and Lipoprotein Metabolism in Children and Adolescents.
His MSc project deals with genotypically different α-thalassaemia patients and their α/β globin ratios. During his time in London Kyriacos worked at University College Hospital Laboratories under the Supervision of Mr Manolis Gavalas. In 2007 & 2008 he received an MSc in Biochemistry and Microbiology respectively from the The International Accreditation Agency for Online Universities (IAAOU) by distant learning.
In 2009 he received a certificate for First Aid and in 2010 for Phlebotomy Services from the Phebotomy Training Services UK. He is a member of the American Association of Clinical Chemistry (AACC), the AOAC (dedicated to anlytical excellence) and a Fellow of the Institute of Biomedical Science U.K.(FIBMS).
From 2005-2010 he was a member of the Board of Directors of The Association of Clinical Laboratory Directors, Biomedical and Clinical Laboratory Scientists (ACLDBCLS) of Cyprus. Since 2001 he is a Laboratory Manager at Yiannoukas Medical Laboratories Ltd www.LABcy.com a multi-discipline Laboratory in Cyprus.
Kyriacos Yiannouka received his BSc in Clinical Sciences from the University of London in 1997 with First Class Honours and his MSc in Haematology with Merit in 1998. During his final BSc year at Kings College London he carried out an Experimental Project under the supervision of Professor Kypros Nicholaides at the Harris Birthright Centre at Kings College Hospital. The projects aim was to determine the prevalence of antiphospholipid antibodies (lupus anticoagulant and/or anticardiolipin antibodies) in the plasma of women with spontaneous abortion or foetal death during their pregnancy and with no history of previous foetal loss.
YML as member of Biomedicine group of companies, is in a position to offer every possible Immunological and Histopathological examination no matter how specialized or innovative it is.
The results are the subject of specialized know-how of biomedicine's fully and modern equipped laboratories and its team of highly trained specialists, as well as special collaborations it has with reference centers abroad such as Mayo Clinic and others.
YML’s policy was always to offer various groups of examinations, that are commonly undertaken by citizens, at special discount prices, allowing all citizens to enjoy quality services for their wellbeing.
This policy has been enhanced since YML became member of Biomedicine group of companies. Biomedicine runs a monthly promotions policy program, which offer's monthly offers to all citizens enabling them to receive special prices for common or very expensive otherwise examinations, celebrating in that way relevant events established by the World Health Organization (WHO) and other relevant organizations.